Mobile phone use and risk of glioma in 5 North European countries
Corresponding Author
Anna Lahkola
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Fax: +358-9-759-88-670.
STUK, Radiation and Nuclear Safety Authority, P.O. Box 14, FIN-00881, Helsinki, FinlandSearch for more papers by this authorAnssi Auvinen
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorJani Raitanen
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorMinouk J. Schoemaker
Section of Epidemiology, Institute of Cancer Research, Sutton
Search for more papers by this authorHelle C. Christensen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorMaria Feychting
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorChristoffer Johansen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorLars Klæboe
Institute of Population-Based Cancer Research, The Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorStefan Lönn
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorAnthony J. Swerdlow
Section of Epidemiology, Institute of Cancer Research, Sutton
Search for more papers by this authorTore Tynes
Institute of Population-Based Cancer Research, The Cancer Registry of Norway, Oslo, Norway
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorTiina Salminen
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorCorresponding Author
Anna Lahkola
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Fax: +358-9-759-88-670.
STUK, Radiation and Nuclear Safety Authority, P.O. Box 14, FIN-00881, Helsinki, FinlandSearch for more papers by this authorAnssi Auvinen
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorJani Raitanen
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorMinouk J. Schoemaker
Section of Epidemiology, Institute of Cancer Research, Sutton
Search for more papers by this authorHelle C. Christensen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorMaria Feychting
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorChristoffer Johansen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorLars Klæboe
Institute of Population-Based Cancer Research, The Cancer Registry of Norway, Oslo, Norway
Search for more papers by this authorStefan Lönn
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorAnthony J. Swerdlow
Section of Epidemiology, Institute of Cancer Research, Sutton
Search for more papers by this authorTore Tynes
Institute of Population-Based Cancer Research, The Cancer Registry of Norway, Oslo, Norway
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorTiina Salminen
STUK, Radiation and Nuclear Safety Authority, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorAbstract
Public concern has been expressed about the possible adverse health effects of mobile telephones, mainly related to intracranial tumors. We conducted a population-based case–control study to investigate the relationship between mobile phone use and risk of glioma among 1,522 glioma patients and 3,301 controls. We found no evidence of increased risk of glioma related to regular mobile phone use (odds ratio, OR = 0.78, 95% confidence interval, CI: 0.68, 0.91). No significant association was found across categories with duration of use, years since first use, cumulative number of calls or cumulative hours of use. When the linear trend was examined, the OR for cumulative hours of mobile phone use was 1.006 (1.002, 1.010) per 100 hr, but no such relationship was found for the years of use or the number of calls. We found no increased risks when analogue and digital phones were analyzed separately. For more than 10 years of mobile phone use reported on the side of the head where the tumor was located, an increased OR of borderline statistical significance (OR = 1.39, 95% CI 1.01, 1.92, p trend 0.04) was found, whereas similar use on the opposite side of the head resulted in an OR of 0.98 (95% CI 0.71, 1.37). Although our results overall do not indicate an increased risk of glioma in relation to mobile phone use, the possible risk in the most heavily exposed part of the brain with long-term use needs to be explored further before firm conclusions can be drawn. © 2007 Wiley-Liss, Inc.
References
- 1 Valberg PA. Radiofrequency radiation (RFR): the nature of exposure and carcinogenic potential. Cancer Causes Control 1997; 8: 323–32.
- 2 National Radiological Protection Board (NRPB). Mobile phones and health 2004: report by the board of NRPB. Doc NRPB 2004; 15: 1–114.
- 3 Hardell L, Näsman Å, PÅhlson A, Hallquist A, Hansson Mild K. Use of cellular telephones and the risk for brain tumours: a case–control study. Int J Oncol 1999; 15: 113–6.
- 4 Muscat JE, Malkin MG, Thompson S, Shore RE, Stellman SD, McRee D, Neugut AI, Wynder EL. Handheld cellular telephone use and risk of brain cancer. JAMA 2000; 284: 3001–7.
- 5 Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS. Cellular-telephone use and brain tumors. N Engl J Med 2001; 344: 79–86.
- 6 Johansen C, Boice JD, McLaughlin JK, Olsen JH. Cellular telephones and cancer—a nationwide cohort study in Denmark. J Natl Cancer Inst 2001; 93: 203–7.
- 7 Auvinen A, Hietanen M, Luukkonen R, Koskela R-S. Brain tumors and salivary gland cancers among cellular telephone users. Epidemiology 2002; 13: 356–9
- 8 Muscat JE, Malkin MG, Shore RE, Thompson S, Neugut AI, Stellman SD, Bruce J. Handheld cellular telephones and risk of acoustic neuroma. Neurology 2002; 58: 1304–6.
- 9 Christensen HC, Schüz J, Kosteljanetz M, Poulsen HS, Thomsen J, Johansen C. Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol 2004; 159: 277–83.
- 10 Lönn S, Ahlbom A, Hall P, Feychting M. Mobile phone use and the risk of acoustic neuroma. Epidemiology 2004; 15: 653–9.
- 11 Lönn S, Ahlbom A, Hall P, Feychting M, Swedish Interphone Study Group. Long-term mobile phone use and brain tumor risk. Am J Epidemiol 2005; 161: 526–35.
- 12 Christensen HC, Schutz J, Kosteljanetz M, Poulsen HS, Boice JD,Jr, McLaughlin JK, Johansen C. Cellular telephones and risk for brain tumors: a population-based, incident case–control study. Neurology 2005; 64: 1189–95.
- 13 Schoemaker MJ, Swerdlow AJ, Ahlbom A, Auvinen A, Blaasaas KG, Cardis E, Christensen HC, Feychting M, Hepworth SJ, Johansen C, Klæboe L, Lönn S, et al. Mobile phone use and risk of acoustic neuroma: results of the interphone case–control study in five North European countries. Br J Cancer 2005; 93: 842–8.
- 14 Hepworth SJ, Schoemaker MJ, Muir KR, Swerdlow AJ, van Tongeren MJ, McKinney PA. Mobile phone use and risk of glioma in adults: case–control study. BMJ 2006; 332: 883–7.
- 15 Schuz J, Bohler E, Berg G, Schlehofer B, Hettinger I, Schlaefer K, Wahrendorf J, Kunna-Grass K, Blettner M. Cellular phones, cordless phones, and the risks of glioma and meningioma (Interohone Study Group, Germany). Am J Epidemiol 2006; 163: 512–20.
- 16 Hardell L, Hallquist A, Hansson Mild K, Carlberg M, Påhlson A, Lilja A. Cellular and cordless telephones and the risk for brain tumours. Eur J Cancer Prev 2002; 11: 377–86.
- 17 Hardell L, Carlberg M, Hansson Mild K. Case–control study on cellular and cordless telephones and the risk for acoustic neuroma or meningioma in patients diagnosed 2000–2003. Neuroepidemiology 2005; 25: 120–8.
- 18 Hardell L, Carlberg M, Mild KH. Case–control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000–2003. Environ Res 2006; 100: 232–41.
- 19 Hardell L, Carlberg M, Hansson Mild K. Pooled analysis of two case–control studies on use of cellular and cordless telephones and the risk for malignant brain tumours diagnosed in 1997–2003. Int Arch Occup Environ Health 2006; 79: 630–9.
- 20 Cardis E, Kilkenny M. International case–control study of adult brain, head and neck tumours: results of the feasibility study. Radiat Prot Dosimetry 1999; 83: 179–83.
- 21 Editorial. Number of cellular subscribers in West European countries, 1984–1995. Mobile Commun 1996; 188: 11.
- 22 StataCorp. Stata statistical software: release 9.0. Texas. Stata Corporation: College Station, 2005.
- 23 Ahlbom A, Green A, Kheifets L, Savitz D, Swerdlow A, ICNIRP (International Committee for Non-Ionizing Radiation Protection) Standing Committee on Epidemiology. Epidemiology of health effects of radiofrequency exposure. Environ Health Perspect 2004; 112: 1741–54.
- 24 Lahkola A, Tokola K, Auvinen A. Meta-analysis of mobile phone use and intracranial tumors. Scand J Work Environ Health 2006; 32: 171–7.
- 25 Lahkola A, Salminen T, Auvinen A. Selection bias due to differential participation in a case–control study of mobile phone use and brain tumors. Ann Epidemiol 2005; 15: 321–5.
- 26 Parslow RC, Hepworth SJ, McKinney PA. Recall of past use of mobile phone handsets. Radiat Prot Dosimetry 2003; 106: 233–40.
- 27 Samkange-Zeeb F, Berg G, Blettner M. Validation of self-reported cellular phone use. J Expo Anal Environ Epidemiol 2004; 14: 245–8.
- 28 Berg G, Schutz J, Zamkange-Zeeb F, Blettner M. Assessment of radiofrequency exposure from cellular telephone daily use in an epidemiological study: German validation study of the international case–control study of cancers of the brain—Interphone study. J Expo Anal Environ Epidemiol 2005; 15: 217–24.
- 29 Vrijheid M, Cardis E, Armstrong BK, Auvinen A, Berg G, Blaasaas KG, Brown J, Carroll M, Chetrit A, Christensen HC, Deltour I, Feychting M, et al. Validation of short term recall of mobile phone use for the Interphone study. Occup Environ Med 2006; 63: 237–43.